Literature DB >> 26553465

Global Changes in Mycoplasma gallisepticum Phase-Variable Lipoprotein Gene vlhA Expression during In Vivo Infection of the Natural Chicken Host.

K Pflaum1, E R Tulman1, J Beaudet1, X Liao1, S J Geary2.   

Abstract

Mycoplasma gallisepticum is the primary etiologic agent of chronic respiratory disease in poultry, a disease largely affecting the respiratory tract and causing significant economic losses worldwide. Immunodominant proteins encoded by members of the variable lipoprotein and hemagglutinin (vlhA) gene family are thought to be important for mechanisms of M. gallisepticum-host interaction, pathogenesis, and immune evasion, but their exact role and the overall nature of their phase variation are unknown. To better understand these mechanisms, we assessed global transcriptomic vlhA gene expression directly from M. gallisepticum populations present on tracheal mucosae during a 7-day experimental infection in the natural chicken host. Here we report differences in both dominant and minor vlhA gene expression levels throughout the first week of infection and starting as early as day 1 postinfection, consistent with a functional role not dependent on adaptive immunity for driving phase variation. Notably, data indicated that, at given time points, specific vlhA genes were similarly dominant in multiple independent hosts, suggesting a nonstochastic temporal progression of dominant vlhA gene expression in the colonizing bacterial population. The dominant expression of a given vlhA gene was not dependent on the presence of 12-copy GAA trinucleotide repeats in the promoter region and did not revert to the predominate vlhA gene when no longer faced with host pressures. Overall, these data indicate that vlhA phase variation is dynamic throughout the earliest stages of infection and that the pattern of dominant vlhA expression may be nonrandom and regulated by previously unrecognized mechanisms.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26553465      PMCID: PMC4693984          DOI: 10.1128/IAI.01092-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  pMGA phenotypic variation in Mycoplasma gallisepticum occurs in vivo and is mediated by trinucleotide repeat length variation.

Authors:  M D Glew; G F Browning; P F Markham; I D Walker
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence.

Authors:  L Papazisi; S Frasca; M Gladd; X Liao; D Yogev; S J Geary
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

3.  Transcriptome analysis reveals novel regulatory mechanisms in a genome-reduced bacterium.

Authors:  Pavel V Mazin; Gleb Y Fisunov; Alexey Y Gorbachev; Kristina Y Kapitskaya; Ilya A Altukhov; Tatiana A Semashko; Dmitry G Alexeev; Vadim M Govorun
Journal:  Nucleic Acids Res       Date:  2014-10-31       Impact factor: 16.971

4.  GAA trinucleotide repeat region regulates M9/pMGA gene expression in Mycoplasma gallisepticum.

Authors:  L Liu; K Dybvig; V S Panangala; V L van Santen; C T French
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  MalF is essential for persistence of Mycoplasma gallisepticum in vivo.

Authors:  Chi-Wen Tseng; Anna Kanci; Christine Citti; Renate Rosengarten; Chien-Ju Chiu; Zheng-Hong Chen; Steven J Geary; Glenn F Browning; Philip F Markham
Journal:  Microbiology       Date:  2013-05-08       Impact factor: 2.777

6.  Trinucleotide GAA repeats dictate pMGA gene expression in Mycoplasma gallisepticum by affecting spacing between flanking regions.

Authors:  Li Liu; Victor S Panangala; Kevin Dybvig
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

7.  Extensive variation in surface lipoprotein gene content and genomic changes associated with virulence during evolution of a novel North American house finch epizootic strain of Mycoplasma gallisepticum.

Authors:  E R Tulman; X Liao; S M Szczepanek; D H Ley; G F Kutish; S J Geary
Journal:  Microbiology       Date:  2012-05-24       Impact factor: 2.777

8.  Mycoplasma gallisepticum in vivo induced antigens expressed during infection in chickens.

Authors:  Merav Ron; Anna Gorelick-Ashkenazi; Sharon Levisohn; Ran Nir-Paz; Steven J Geary; Edan Tulman; Inna Lysnyansky; David Yogev
Journal:  Vet Microbiol       Date:  2014-12-18       Impact factor: 3.293

9.  Computational analysis of bacterial RNA-Seq data.

Authors:  Ryan McClure; Divya Balasubramanian; Yan Sun; Maksym Bobrovskyy; Paul Sumby; Caroline A Genco; Carin K Vanderpool; Brian Tjaden
Journal:  Nucleic Acids Res       Date:  2013-05-28       Impact factor: 16.971

10.  DNA repair in Mycoplasma gallisepticum.

Authors:  Alexey Y Gorbachev; Gleb Y Fisunov; Mark Izraelson; Darya V Evsyutina; Pavel V Mazin; Dmitry G Alexeev; Olga V Pobeguts; Tatyana N Gorshkova; Sergey I Kovalchuk; Dmitry E Kamashev; Vadim M Govorun
Journal:  BMC Genomics       Date:  2013-10-23       Impact factor: 3.969

View more
  19 in total

1.  Transcriptional Profiling of the Chicken Tracheal Response to Virulent Mycoplasma gallisepticum Strain Rlow.

Authors:  J Beaudet; E R Tulman; K Pflaum; X Liao; G F Kutish; S M Szczepanek; L K Silbart; S J Geary
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

2.  Variable Lipoprotein Hemagglutinin A Gene (vlhA) Expression in Variant Mycoplasma gallisepticum Strains In Vivo.

Authors:  K Pflaum; E R Tulman; J Beaudet; J Canter; S J Geary
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

3.  Immunologic Pathways in Protective versus Maladaptive Host Responses to Attenuated and Pathogenic Strains of Mycoplasma gallisepticum.

Authors:  Jessica Beaudet; Edan R Tulman; Katherine Pflaum; Jessica A Canter; Lawrence K Silbart; Steven J Geary
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

4.  Differential Response of the Chicken Trachea to Chronic Infection with Virulent Mycoplasma gallisepticum Strain Ap3AS and Vaxsafe MG (Strain ts-304): a Transcriptional Profile.

Authors:  Glenn F Browning; Nadeeka K Wawegama; Sathya N Kulappu Arachchige; Neil D Young; Pollob K Shil; Alistair R Legione; Anna Kanci Condello
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

5.  The Variable Internal Structure of the Mycoplasma penetrans Attachment Organelle Revealed by Biochemical and Microscopic Analyses: Implications for Attachment Organelle Mechanism and Evolution.

Authors:  Steven L Distelhorst; Dominika A Jurkovic; Jian Shi; Grant J Jensen; Mitchell F Balish
Journal:  J Bacteriol       Date:  2017-05-25       Impact factor: 3.490

6.  Transcriptional and Pathological Host Responses to Coinfection with Virulent or Attenuated Mycoplasma gallisepticum and Low-Pathogenic Avian Influenza A Virus in Chickens.

Authors:  J A Canter; E R Tulman; J Beaudet; D-H Lee; M May; S M Szczepanek; S J Geary
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

7.  Evaluation of Glycyrrhizic Acid Therapeutic Effect and Safety in Mycoplasma gallisepticum (HS Strain)-Infected Arbor Acres Broilers.

Authors:  Fuli Hu; Ronglong Luo; Shuwen Duan; Qiao Guo; Lulu Wang; Guangyang Jiang; Changyong Fan; Mengyun Zou; Tengfei Wang; Yingjie Wang; Yingfei Sun; Xiuli Peng
Journal:  Animals (Basel)       Date:  2022-05-17       Impact factor: 3.231

8.  Gene Silencing through CRISPR Interference in Mycoplasmas.

Authors:  Daria V Evsyutina; Gleb Y Fisunov; Olga V Pobeguts; Sergey I Kovalchuk; Vadim M Govorun
Journal:  Microorganisms       Date:  2022-06-05

9.  Comprehensive RNA-Seq Profiling to Evaluate the Sheep Mammary Gland Transcriptome in Response to Experimental Mycoplasma agalactiae Infection.

Authors:  Rohini Chopra-Dewasthaly; Melanie Korb; René Brunthaler; Reinhard Ertl
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

10.  Persistence of Functional Protein Domains in Mycoplasma Species and their Role in Host Specificity and Synthetic Minimal Life.

Authors:  Tjerko Kamminga; Jasper J Koehorst; Paul Vermeij; Simen-Jan Slagman; Vitor A P Martins Dos Santos; Jetta J E Bijlsma; Peter J Schaap
Journal:  Front Cell Infect Microbiol       Date:  2017-02-07       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.